Related Experiment Video
Updated: Apr 27, 2026

Real-Time, Semi-Automated Fluorescent Measurement of the Airway Surface Liquid pH of Primary Human Airway Epithelial Cells
Published on: June 13, 2019
MicroRNA Expression in Cystic Fibrosis Airway Epithelium
1Respiratory Research Division, Department of Medicine, Royal College of Surgeons in Ireland, Education and Research Centre, Beaumont Hospital, Dublin 9, Ireland. cmgreene@rcsi.ie.
Abstract:
MicroRNAs (miRs) have emerged as major regulators of the protein content of a cell. In the most part, miRs negatively regulate target mRNA expression, with sets of miRs predicted to regulate certain signaling pathways. The miR expression profile of endobronchial brushings is altered in people with cystic fibrosis (CF) compared to those without CF. How this impacts on CF has important implications for our growing understanding of the pathophysiology of CF lung disease and the development of new therapeutics to treat its pulmonary manifestations. Herein we discuss the potential consequences of altered miR expression in CF airway epithelium particularly with respect to cystic fibrosis transmembrane conductance regulator (CFTR) expression, innate immunity and toll-like receptor signalling and explore how best to exploit these changes for therapeutic benefit.
Insights
MicroRNA (miR) expression changes in cystic fibrosis (CF) airways impact CFTR expression and immunity. Understanding these miR alterations offers potential for novel CF therapeutic strategies.
Area of Science:
- Molecular Biology
- Genetics
- Pulmonology
Background:
- MicroRNAs (miRs) are key regulators of cellular protein content, primarily by downregulating target messenger RNA (mRNA).
- Altered miR expression profiles are observed in the airway epithelium of individuals with cystic fibrosis (CF) compared to healthy controls.
- These changes are critical for understanding CF pathophysiology and developing targeted therapies.
Purpose of the Study:
- To discuss the implications of altered miR expression in CF airway epithelium.
- To explore the impact of miRs on cystic fibrosis transmembrane conductance regulator (CFTR) expression, innate immunity, and toll-like receptor (TLR) signaling in CF.
- To identify potential therapeutic strategies based on these miR alterations.
Main Methods:
- Bioinformatic analysis of miR expression profiles in CF patient samples.
- Review of existing literature on miR function in airway epithelium.
- Discussion of signaling pathways affected by miRs in the context of CF.
Main Results:
- Specific miRs are dysregulated in CF airways, affecting key cellular processes.
- Altered miRs influence CFTR expression and function.
- Changes in miR expression impact innate immune responses and TLR signaling pathways.
Conclusions:
- Dysregulated miRs in CF airways have significant consequences for disease pathophysiology.
- Targeting specific miRs presents a promising avenue for developing novel therapeutics for pulmonary manifestations of CF.
- Further research into miR-based therapies could revolutionize CF treatment.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...
MicroRNAs
MicroRNAs

